Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22
Phase 32

Trial Status

Completed4

Role Distribution

Other Roles4

Activity Timeline

Clinical Trials (4)

NCT02207621Phase 3Completed
Evaluation of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Glaucoma and Ocular Hypertension
Ocular HypertensionOpen-angle Glaucoma
StudydirectorStart date: 2014-07-01
NCT01528787Phase 2Completed
Study of AR-13324 in Patients With Elevated Intraocular Pressure
Ocular HypertensionOpen Angle Glaucoma
Studydirector

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Aerie Pharmaceuticals, Inc.

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Gerhard Garhöfer, MD

Department of Clinical Pharmacology, Medical University of Vienna

Moderately Similar
10 trials

Shared therapeutic areas:

Glaucoma, Open-AngleOcular Hypertension
Similarity Score30%

Theresa Landry, PhD

Alcon Research

Moderately Similar
4 trials

Shared therapeutic areas:

Glaucoma, Open-AngleOcular Hypertension
Similarity Score30%

Michelle Chen, PhD

Allergan

Moderately Similar
5 trials

Shared therapeutic areas:

Ocular HypertensionGlaucoma, Open-Angle
Similarity Score30%

Alcon Investigators

Alcon Research

Moderately Similar
5 trials

Shared therapeutic areas:

Glaucoma, Open-AngleOcular Hypertension
Similarity Score30%

William C. Stewart, MD

Pharmaceutical Research Network, LLC

Moderately Similar
6 trials

Shared therapeutic areas:

Glaucoma, Open-AngleOcular Hypertension
Similarity Score30%

Marcelo Ayala, MD, PhD

Vastra Gotaland Region

Moderately Similar
3 trials

Shared therapeutic areas:

Glaucoma, Open-AngleOcular Hypertension
Similarity Score30%

Quintus Ngumah, OD, PhD

Bausch & Lomb Incorporated

Moderately Similar
4 trials

Shared therapeutic areas:

Ocular HypertensionGlaucoma, Open-Angle
Similarity Score30%

Kerry Stephens, O.D.

Glaukos Corporation

Moderately Similar
5 trials

Shared therapeutic areas:

Glaucoma, Open-AngleOcular Hypertension
Similarity Score30%

Kerry Stephens, OD

Glaukos Corporation

Moderately Similar
4 trials

Shared therapeutic areas:

Glaucoma, Open-AngleOcular Hypertension
Similarity Score30%

Tobias Dahlgren, MD

Vastra Gotaland Region

Moderately Similar
3 trials

Shared therapeutic areas:

Glaucoma, Open-AngleOcular Hypertension
Similarity Score30%

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT02207621Phase 3StudyDirector

Evaluation of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Glaucoma and Ocular Hypertension

Ocular HypertensionOpen-angle Glaucoma
Completed
NCT01528787Phase 2StudyDirector

Study of AR-13324 in Patients With Elevated Intraocular Pressure

Ocular HypertensionOpen Angle Glaucoma
Completed
NCT01731002Phase 2StudyDirector

Study Comparing the Safety and Efficacy of AR-13324 to Latanoprost in Patients With Elevated Intraocular Pressure

Ocular HypertensionOpen Angle Glaucoma
Completed
NCT02207491Phase 3StudyDirector

Double-masked Study of AR-13324 Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension

Ocular HypertensionOpen-angle Glaucoma
Completed

All 4 trials loaded